BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA

被引:251
作者
MORGANROTH, J [1 ]
LEVY, RI [1 ]
FREDRICKSON, DS [1 ]
机构
[1] NHLI, MOLEC DIS BRANCH, BETHESDA, MD 20014 USA
关键词
D O I
10.7326/0003-4819-82-2-158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:158 / 174
页数:17
相关论文
共 34 条
[11]  
FREDRICKSON DS, 1972, METABOLIC BASIS INHE, P545
[12]   IMMUNOREACTIVE INSULIN, GLUCOSE TOLERANCE, AND CARBOHYDRATE INDUCIBILITY IN TYPES 2, 3, 4, AND V HYPERLIPOPROTEINEMIA [J].
GLUECK, CJ ;
LEVY, RI ;
FREDRICKSON, DS .
DIABETES, 1969, 18 (11) :739-+
[13]  
GOCHMAN N, 1972, CLIN CHEM, V18, P943
[14]  
GOCHMAN N, 1971, CLIN CHEM, V17, P1154
[15]  
GODOLPHIN WJ, 1972, LANCET, V1, P209
[16]  
GOFMAN JOHN W., 1954, PLASMA [MILAN], V2, P413
[17]  
HALL M, 1974, CIRCULATION S3, V50, P449
[18]   PRIMARY DYSBETA-LIPOPROTEINEMIA - PREDOMINANCE OF A SPECIFIC APOPROTEIN SPECIES IN TRIGLYCERIDE-RICH LIPOPROTEINS [J].
HAVEL, RJ ;
KANE, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (07) :2015-2019
[19]   ABNORMAL LIPID COMPOSITION OF VERY LOW-DENSITY LIPOPROTEINS IN DIAGNOSIS OF BROAD-BETA DISEASE (TYPE-III HYPERLIPOPROTEINEMIA) [J].
HAZZARD, WR ;
BIERMAN, EL ;
PORTE, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1972, 21 (11) :1009-+
[20]  
HOLIMON JL, 1971, ARCH PATHOL, V92, P415